Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2019

Jul 22, 2019

SELL
$39.4 - $42.7 $194,045 - $210,297
-4,925 Closed
0 $0
Q1 2019

Apr 11, 2019

BUY
$38.57 - $42.69 $189,957 - $210,248
4,925 New
4,925 $205,000
Q4 2018

Feb 04, 2019

SELL
$37.8 - $42.69 $214,514 - $242,265
-5,675 Closed
0 $0
Q3 2018

Oct 10, 2018

SELL
$39.75 - $42.69 $18,881 - $20,277
-475 Reduced 7.72%
5,675 $227,000
Q2 2018

Jul 26, 2018

SELL
$39.61 - $42.76 $1,980 - $2,138
-50 Reduced 0.81%
6,150 $247,000
Q1 2018

Apr 17, 2018

SELL
$36.18 - $40.15 $9,045 - $10,037
-250 Reduced 3.88%
6,200 $242,000
Q4 2017

Jan 29, 2018

BUY
$35.34 - $41.9 $44,175 - $52,375
1,250 Added 24.04%
6,450 $228,000
Q3 2017

Oct 19, 2017

BUY
$39.44 - $41.55 $205,088 - $216,059
5,200
5,200 $211,000

Others Institutions Holding GSK

About GSK PLC


  • Ticker GSK
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,033,689,984
  • Market Cap $69.3B
  • Description
  • GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...
More about GSK
Track This Portfolio

Track Murphy Capital Management Inc Portfolio

Follow Murphy Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Murphy Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Murphy Capital Management Inc with notifications on news.